Perrigo announced that it has received final approval from the FDA for Cetirizine HCl Oral Solution USP, the generic version of McNeil Consumer’s Children’s Zyrtec Allergy Syrup.

RELATED: Allergic Disorders Resource Center

Zyrtec is an antihistamine indicated for indoor and outdoor allergies in children >2 years of age. Cetirizine HCl antagonizes the effect of histamine on histamine receptors and reduces associated allergy symptoms, such as itching and urticaria.

Cetirizine HCl Oral Solution will be available in 1 mg/mL strength in a bubble gum flavor. Perrigo expects to begin shipments of the product during the upcoming cough/cold/flu season.

For more information call (866) 634-9120 or visit